Effort and neuropsychological performance in HIV-infected individuals on stable combination antiretroviral therapy
- PMID: 28895090
- PMCID: PMC5656505
- DOI: 10.1007/s13365-017-0557-5
Effort and neuropsychological performance in HIV-infected individuals on stable combination antiretroviral therapy
Abstract
The expression of cognitive symptoms associated with HIV varies over time and across individuals. This pattern may reflect transient contextual factors, including the degree of effort exerted by individuals undergoing cognitive testing. The present study examined whether effort corresponds to the expression of persistent HIV-related cognitive impairment among individuals receiving combination antiretroviral therapy (cART). HIV+ individuals (n = 111) averaged 48.2 (14.9) years of age and 13.0 (2.7) years of education and HIV- individuals (n = 92) averaged 34.9 (17.2) years of age and 13.5 (1.9) years of education. Participants completed a neuropsychological battery and a clinically validated measure of effort (Test of Memory Malingering, trial 1). Results revealed that the vast majority of HIV+ (85%) and HIV- (89%) individuals performed above published guidelines for adequate effort. Furthermore, the expression of cognitive impairment in HIV was not related to effort performance. The results were unchanged when examining HIV+ individuals with and without viral suppression. Finally, disability and disability-seeking status, and a proxy measure of apathy did not correspond to effort levels in HIV+ individuals. These findings suggest that variability in the expression of cognitive impairment in the cART era is unlikely to represent overt effort failures or other confounds unrelated to the disease. Persistent cognitive impairment in HIV likely represents historical and/or ongoing disease mechanisms despite otherwise successful treatment.
Keywords: Cognition; Effort; HIV; Neuropsychological performance; Test of Memory Malingering (TOMM).
Figures


References
-
- Amato MP, Ponziani G, Siracusa G, Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Archives of Neurology. 2001;58(10):1602–1606. - PubMed
-
- American Psychological Association. Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychological Association; 2000.
-
- Antinori A, Arendt G, Becker JK, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789–99. - PMC - PubMed
-
- Ashendorf L, Constantinos M, McCaffrey RJ. The effect of depression and anxiety on the TOMM in community-dwelling older adults. Archives of Clinical Neuropsychology. 2004;19:125–130. - PubMed
-
- Batt K, Shores EA, Chekaluk E. The effect of distraction on the Word Memory Test and Test of Memory Malingering performance in patients with a severe brain injury. Journal of International Neuropsychological Society. 2008;14(6):1074–80. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources